Regulus Therapeutics
RGLS
#6971
Rank
NZ$0.96 B
Marketcap
NZ$13.98
Share price
0.00%
Change (1 day)
419.27%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: NZ$0.96 Billion

As of December 2025 Regulus Therapeutics has a market cap of NZ$0.96 Billion. This makes Regulus Therapeutics the world's 6971th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.96 B441.08%
2024NZ$0.17 B336.97%
2023NZ$40.93 M12.64%
2022NZ$36.33 M-46.02%
2021NZ$67.31 M-43.34%
2020NZ$0.11 B327.77%
2019NZ$27.77 M127.05%
2018NZ$12.23 M-91.96%
2017NZ$0.15 B-11.45%
2016NZ$0.17 B-74.38%
2015NZ$0.67 B-33.03%
2014NZ$1.00 B166.64%
2013NZ$0.37 B36.94%
2012NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
NZ$169.73 B 17,439.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
NZ$200.70 B 20,639.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$44.31 B 4,478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$491.02 B 50,638.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
NZ$90.68 B 9,270.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.25 B-73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$190.78 B 19,614.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.10 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA